Harbin Pharmaceutical Group Co., Ltd. Class ASSE: 600664

"Harbin Pharmaceutical Group Co., Ltd."Semi-annual Report for 2026

Aug 26, 2026 · Issued by Harbin Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange

Semi-annual Report for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Harbin Pharmaceutical Group Co., Ltd. Class A

"Harbin Pharmaceutical Group Co., Ltd."Announcement on Abnormal Fluctuations in Stock TradingAug 12
"Harbin Pharmaceutical Group Co., Ltd."Announcement on the Proposed Selection in the 12th Batch of National Centralized Drug ProcurementAug 4
"Harbin Pharmaceutical Group Co., Ltd."Announcement on the Affiliated Enterprise's Receipt of the Approval Notice for the Marketing Application of a Chemical APIJul 30
"Harbin Pharmaceutical Group Co., Ltd."Announcement on Severe Abnormal Fluctuations in Stock Trading and Risk WarningJul 24

All Harbin Pharmaceutical Group Co., Ltd. Class A news releases